Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Oneida › NPI 1962408203
Hospital

Oneida Health Systems, INC

Oneida Health Systems, INC was paid $17.62M by Medicaid between Jan 2018 and Dec 2024, across 272 billing codes. Its largest line is 99283, emergency room visit (moderate) — 8.5% of everything it billed.

33Billing provider infoONEIDA HEALTH SYSTEMS, INC
ONEIDA, NY 13421
33aNPI1962408203assigned 06/22/2005
28Total paid$17.62M
24GClaims519,731
24DCodes billed272
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#65 of 231
Median peer was paid$561K
This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,352$38K
201925,593$834K
202089,452$3.02M
2021110,593$3.64M
2022110,633$3.57M
2023108,524$3.91M
2024incomplete73,584$2.62M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.5% 11,350 10,877 $1.50M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7.7% 14,560 12,373 $1.35M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.5% 10,877 10,185 $1.32M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.7% 9,140 8,796 $1.18M
96361 Intravenous infusion, hydration; each additional hour 5.6% 4,656 4,146 $991K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.6% 3,757 3,657 $980K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 5.4% 8,867 8,297 $948K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.5% 6,752 6,334 $619K
80053 Comprehensive metabolic panel 3.2% 31,730 28,530 $562K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 3.2% 1,121 1,115 $559K
70450 Computed tomography, head or brain; without contrast material 2.9% 1,821 1,795 $505K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.6% 7,522 2,165 $453K
260 more codes
45380 Colonoscopy, flexible; with biopsy, single or multiple 2.5% 680 $440K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 1,501 $412K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.9% 1,214 $339K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.9% 6,732 $334K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.7% 13,087 $291K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 2,373 $288K
59025 Fetal non-stress test 1.2% 1,338 $218K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 995 $170K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,252 $168K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 106 $161K
36415 Collection of venous blood by venipuncture <1% 29,402 $158K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,306 $131K
71275 Computed tomographic angiography, chest, with contrast material <1% 417 $125K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,047 $106K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,111 $104K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,029 $99K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,722 $95K
97161 <1% 1,125 $93K
84443 Thyroid stimulating hormone (TSH) <1% 11,168 $89K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,116 $85K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 116 $81K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,241 $78K
80048 Basic metabolic panel (calcium, ionized) <1% 4,654 $65K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 30,089 $60K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,844 $60K
80061 Lipid panel <1% 8,557 $59K
88142 <1% 2,584 $54K
83036 Hemoglobin; glycosylated (A1C) <1% 6,247 $53K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 208 $52K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,667 $51K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 6,586 $49K
87088 <1% 9,886 $48K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 604 $48K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,906 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,553 $46K
87660 <1% 3,846 $45K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 510 $43K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 401 $43K
99201 <1% 409 $42K
88342 <1% 853 $42K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 317 $42K
84439 <1% 4,734 $41K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 1,482 $40K
86850 <1% 2,303 $40K
87480 <1% 3,526 $40K
87510 <1% 3,320 $37K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 303 $35K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 103 $35K
99203 Doctor's office visit, new patient (routine) <1% 368 $35K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,572 $35K
83880 <1% 1,091 $33K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 299 $33K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 703 $32K
86901 <1% 2,450 $31K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,888 $30K
83655 <1% 2,291 $29K
99215 Doctor's office visit, returning patient (complex) <1% 251 $29K
82607 <1% 2,521 $28K
76641 <1% 1,362 $28K
86900 <1% 2,451 $28K
71046 Radiologic examination, chest; 2 views <1% 5,837 $25K
82728 <1% 2,038 $25K
90686 <1% 1,040 $24K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 170 $23K
87634 <1% 2,077 $23K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 205 $23K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 199 $22K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 534 $22K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 212 $21K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 469 $20K
87077 <1% 3,560 $20K
94060 <1% 238 $20K
86141 <1% 2,616 $19K
73564 <1% 1,757 $19K
93971 <1% 301 $18K
87070 <1% 2,682 $17K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 12 $17K
81025 <1% 5,388 $17K
84153 <1% 957 $16K
84403 <1% 643 $16K
71250 <1% 211 $15K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 100 $15K
86803 <1% 1,656 $14K
87186 <1% 3,201 $14K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 123 $14K
87340 <1% 1,503 $14K
84702 <1% 1,751 $13K
85027 <1% 5,221 $13K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 57 $13K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 122 $13K
78815 Positron emission tomography (PET) for limited area imaging <1% 37 $13K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,936 $12K
80076 <1% 1,200 $11K
76536 <1% 576 $11K
90715 <1% 519 $11K
86762 <1% 829 $11K
86618 <1% 778 $11K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 258 $11K
83540 <1% 2,350 $10K
99441 <1% 96 $10K
87081 <1% 2,213 $10K
73630 <1% 1,754 $9K
88304 <1% 271 $9K
99292 <1% 167 $9K
73610 <1% 1,796 $8K
72110 <1% 590 $8K
96415 <1% 13 $8K
73110 <1% 1,452 $8K
81001 <1% 8,117 $8K
90682 <1% 328 $8K
73030 <1% 1,288 $8K
82784 <1% 720 $7K
81003 <1% 12,305 $7K
83735 <1% 3,902 $7K
73130 <1% 1,382 $7K
76801 <1% 126 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,592 $7K
83550 <1% 1,505 $6K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 7,550 $6K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 474 $6K
H0049 Alcohol and/or drug screening <1% 183 $6K
85610 <1% 2,693 $6K
74018 <1% 1,298 $6K
86665 <1% 296 $6K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,397 $6K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 360 $6K
86592 <1% 1,869 $6K
84466 <1% 534 $6K
85007 <1% 3,488 $5K
82746 <1% 456 $5K
12001 <1% 12 $5K
12002 <1% 12 $5K
85652 <1% 2,449 $4K
84480 <1% 704 $4K
83690 <1% 5,098 $4K
72141 <1% 12 $3K
H1000 Prenatal care, at-risk assessment <1% 113 $3K
85730 <1% 1,804 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 74 $3K
86003 <1% 52 $3K
94726 <1% 45 $3K
70486 <1% 25 $3K
82043 <1% 629 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 3,869 $3K
76830 Ultrasound, transvaginal <1% 67 $3K
86703 <1% 183 $3K
82248 <1% 571 $3K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 24 $3K
71271 <1% 100 $2K
86664 <1% 169 $2K
86038 <1% 511 $2K
90734 <1% 66 $2K
84550 <1% 672 $2K
86663 <1% 170 $2K
86431 <1% 447 $2K
86039 <1% 421 $2K
83001 <1% 105 $2K
84146 <1% 110 $2K
96367 <1% 35 $2K
86617 <1% 120 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 374 $2K
94729 <1% 45 $2K
J1756 Injection, iron sucrose, 1 mg <1% 29 $2K
86706 <1% 184 $2K
87045 <1% 220 $2K
90673 <1% 78 $2K
84703 <1% 1,661 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 638 $2K
87631 <1% 25 $2K
82950 <1% 538 $2K
86308 <1% 490 $1K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,467 $1K
85018 <1% 798 $1K
87899 <1% 207 $1K
84100 <1% 885 $1K
85379 <1% 1,035 $1K
99204 Doctor's office visit, new patient (more involved) <1% 12 $1K
A6010 Collagen based wound filler, dry form, sterile, per gram of collagen <1% 42 $1K
71045 Radiologic examination, chest; single view <1% 1,545 $1K
73080 <1% 253 $1K
87040 <1% 1,660 $1K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 28 $1K
G0008 Administration of influenza virus vaccine <1% 132 $1K
73562 <1% 109 $1K
86709 <1% 140 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 27 $981.72
82550 <1% 417 $967.80
85014 <1% 455 $940.94
86705 <1% 126 $923.87
99173 <1% 12 $835.08
77066 Tomosynthesis, mammo <1% 13 $763.56
73502 <1% 153 $716.84
86480 <1% 12 $645.94
0012A <1% 45 $595.35
82105 <1% 94 $593.86
82150 <1% 159 $560.65
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 21 $558.81
84484 <1% 3,865 $548.83
87328 <1% 37 $462.82
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 29 $448.55
86235 <1% 14 $440.66
87329 <1% 37 $389.87
87177 <1% 51 $379.89
83615 <1% 90 $335.10
81002 <1% 3,010 $328.99
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,032 $303.11
82962 <1% 2,888 $289.12
A4213 Syringe, sterile, 20 cc or greater, each <1% 1,613 $282.94
90651 <1% 12 $255.85
87209 <1% 51 $252.64
83993 <1% 26 $239.19
83605 <1% 1,414 $228.98
90460 Immunization administration through 18 years of age via any route, first or only component <1% 957 $228.56
A9576 Injection, gadoteridol, (prohance multipack), per ml <1% 31 $206.03
76882 <1% 13 $202.11
73590 <1% 40 $192.48
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 13 $180.88
0011A <1% 13 $175.70
73140 <1% 70 $153.60
82977 <1% 42 $150.88
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,282 $150.31
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,648 $129.50
82565 <1% 29 $125.75
80305 <1% 516 $125.45
87420 <1% 17 $99.41
J7030 Infusion, normal saline solution , 1000 cc <1% 1,398 $96.51
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,364 $80.17
87101 <1% 12 $69.39
86225 <1% 16 $63.01
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,202 $62.44
84460 <1% 12 $50.80
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 772 $50.21
84520 <1% 12 $47.40
96376 <1% 353 $45.05
89055 <1% 12 $34.03
71101 <1% 12 $31.83
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 21 $27.90
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 86 $24.83
J2704 Injection, propofol, 10 mg <1% 1,926 $16.06
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,084 $13.51
J0690 Injection, cefazolin sodium, 500 mg <1% 476 $8.53
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 366 $6.80
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,558 $3.61
J7050 Infusion, normal saline solution, 250 cc <1% 88 $2.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,896 $2.20
J1644 Injection, heparin sodium, per 1000 units <1% 189 $1.43
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 323 $0.60
J1170 Injection, hydromorphone, up to 4 mg 0% 12 $0.00
A4615 Cannula, nasal 0% 17 $0.00
95806 0% 26 $0.00
88300 0% 14 $0.00
96127 0% 40 $0.00
L8699 Prosthetic implant, not otherwise specified 0% 12 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 52 $0.00
87430 0% 49 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 14 $0.00
59430 0% 13 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 12 $0.00
90461 0% 90 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOERNIG, FELISSA (CEO/PRESIDENT)